JUNS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Jupiter Neurosciences Inc (JUNS) is not a strong buy for a beginner, long-term investor at this moment. The lack of positive financial performance, absence of significant trading trends, and no clear technical or proprietary trading signals suggest holding off on this investment for now.
The MACD is positive and expanding, which is a mildly bullish signal. However, the RSI is neutral at 33.125, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading close to its pivot level of 0.566, with resistance at 0.623 and support at 0.508. Overall, the technical indicators do not strongly support a buy decision.
The MACD shows a positive expansion, which could indicate some bullish momentum. However, this is not strong enough to justify a buy.
The company has no revenue, a significant net income loss (-$2,288,034), and a negative EPS (-0.07). There are no recent news catalysts, no significant insider or hedge fund activity, and no recent congress trading data. Additionally, the bearish moving averages and lack of proprietary trading signals further weaken the case for buying.
In Q3 2025, the company reported no revenue growth (0% YoY), a significant net income loss of -$2,288,034 (up 287.13% YoY), and a negative EPS of -0.07 (up 250% YoY). Gross margin remains at 0%. These metrics indicate poor financial health and no growth trends.
No analyst rating or price target data available.
